Novartis’ Xolair backed in global urticaria guidelines
admin 6th March 2018 Uncategorised 0Novartis’ Xolair has been recommended in global guidelines for treating chronic spontaneous urticaria in patients unresponsive to antihistamines.
More: Novartis’ Xolair backed in global urticaria guidelines
Source: News